Multiple resistance mechanisms in acute nonlymphoblastic leukemia (ANLL)

Anticancer Research

Volumn 18, Issue 2 B, 1998, Pages 1231-1236

  Sauerbrey, A ^a   Zintl, F ^a   Hermann, J ^a   Volm, M ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Acute nonlymphoblastic leukemia; Glutathione S transferase ; Metallothionein; P glycoprotein 170; Prognosis; Thymidylate synthase; Topoisomerase II

Indexed keywords

CYTARABINE; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; ETOPOSIDE; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P; METALLOTHIONEIN; PREDNISOLONE; THYMIDYLATE SYNTHASE; TIOGUANINE; VINCRISTINE;

ACUTE NONLYMPHOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RECURRENCE; CANCER REGRESSION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; INFANT; LEUKEMIA CELL; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; R FACTOR; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA TOPOISOMERASES, TYPE II; DRUG RESISTANCE, MULTIPLE; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; INFANT; LEUKEMIA, NONLYMPHOCYTIC, ACUTE; MALE; METALLOTHIONEIN; P-GLYCOPROTEIN; PROGNOSIS; RETROSPECTIVE STUDIES; THYMIDYLATE SYNTHASE;

EID: 0031830575     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lehnert M: Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 32 A: 912-920, 1996.
2. Campos L, Guyotat D, Archimbaud E, Calmard-Oriol P, Tsuruo T, Troncy J, Traille D, Fiere D: Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis. Blood 79: 473-476, 1992.
3. Pirker R, Wallner J, Geissler K, Linkesch W, Haas OA, Bettelheim P, Hopfner M, Scherrer R, Valent P, Havelec L, Ludwig H, Lechner K: MDR1 gene expression and treatment outcome in acute myeloid leukemia. J Natl Cancer Inst 83: 708-712, 1991.
4. Sato H, Preisler H, Day R, Raza A, Larson R, Browman G, Goldberg J, Vogler R, Grunwald H, Gottlieb A, Bennet J, Gottesman M, Pastan I: MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukemia. Br J Haematol 75: 340-345, 1990.
5. Sauerbrey A, Zintl F, Volm M: Resistance factors and proliferative activity in childhood acute nonlymphoblastic leukemia. Int J Oncol 5: 841-845, 1994.
6. Black SM, Wolf CR: The role of glutathione-dependent enzymes in drug resistance. Pharmac Ther 51: 139-154, 1991.
7. Waxmann DJ: Glutathione S-transferases: Role in alkylating agents resistance and possible target for modulation chemotherapy-A review. Cancer Res 50: 6449-6454, 1990.
8. Tidefelt U, Elmhorn-Rosenborg A, Paul C, Hao XY, Mannervik B, Eriksson LC: Expression of glutathione transferase π as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res 52: 3281-3285, 1992.
9. Koberda J, Hellmann A: Glutathione S-transferase activity of leukemic cells as a prognostic factor for response to chemotherapy in acute leukemias. Med Oncol Tumor Pharmacother 8: 35-38, 1991.
10. McQuaid S, McCann S, Daly P, Lawlor E, Humphries P: Observations on the transcriptional activity of the gluthathione-S-tranferase π gene in human haematological malignancies and in the peripheral leucocytes of cancer patients under chemotherapy. Br J Cancer 59: 540-543, 1989.
11. Ardalan B, Cooney DA, Jayaram HN, Caricco CK, Glazar RI, Macdonald J, Schein PS: Mechanisms of sensitivity and resistance of murine tumors to 5-fluorouracil. Cancer Res 40: 1431-1437, 1980.
12. Chu E, Drake JC, Koeller DM, Zinn S, Jamis-Dow CA, Chao Yeh G, Allegra CJ: Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cancer cell lines. Mol Pharmacol 39: 136-143, 1990.
13. Volm, M J Mattern: Elevated expression of thymidylate synthase in doxorubicin resistant human non small cell lung carcinoms. Anticancer Res 12: 2293-2296, 1992.
14. Volm M, F Zintl, A Sauerbrey: Thymidylate synthase in childhood acute non-lymphoblastic leukemia. Anticancer Res 14: 1271-1276,1994.
15. Hamer DH: Metallothionein. Ann Rev Biochem 55: 913-951, 1986.
16. Kasahara K, Fujiwara Y, Nishio K, Ohmori T, Sugimoto Y, Komiya K, Matsuda T, Saijo N: Metallothionein content correlates with sensitivity of human small cell lung cancer cell lines to cisplatin. Cancer Res 57: 3237-3242, 1991.
17. Kelly SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS: Overexpression of Metallothionein confers resistance to anticancer drugs. Science 241: 1813-1815, 1988.
18. Schilder RJ, Hall L, Monks A, Handel LM, Fornace AJ, Ozols RF, Fojo AT, Hamilton TC: Metallothionein gene expression and resistance to cisplatin in human ovarian cancers. Int J Cancer 45: 416-422, 1990.
19. Beck WT, Danks MK: Mechanisms of resistance to drugs that inhibit DNA topoisomerases. Cancer Biol 2: 235-244, 1991.
20. McKenna SL, Whitaker JA, Padua RA, Holmes JA: Topoisomerase II expression in normal haemopoietic cells and chronic lymphocytic leukemia: Drug sensitivity or resistance: Leukemia 7: 1199-1203, 1993.
21. Deffie AM, Batra JK, Goldenberg GJ: Direct correlation between DNA topoisomerase II activity and cytotoxicity in adriamycin-sensitive and-resistant P388 leukemia cell lines. Cancer Res 49: 58-62, 1989.
22. Fernandes DJ, Danks MK, Beck WT: Decreased nuclear matrix DNA Topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA. Biochemistry 29: 4235-4241, 1990.
23. Potmesil M, Hsiang YH, Liu LF, Wu HY, Traganos F, Bank B, Silber R: DNA Topoisomerase II as a potential factor in drug resistance of human malignancies. NCI Monogr 4: 105-108, 1989.
24. Bennet JM, Catowsky D, Daniel MT, Flandrin G, Galton GAR, Gralnick HR, Sultan C: Proposal for the classification of the acute leukemias. French American British (FAB) cooperative group. Br J Haematol 33: 451-458, 1976.
25. Hermann J, Zintl F, Krause M, Palme H, Fuchs D, Prager J, Dörffel W, Domula M, Eggers G, Exadaktylos P, Kotte W, Krause I, Kunert W, Mittler U, Möbius D, Reddemann H, Siegert E, Weinmann G: Therapy of acute myelogenous leukemia in childhood-results of the multicenter trial AML 11/87 in East Germany. Kinderärztl Praxis 59: 321-327, 1991.
26. Sauerbrey A, F Zintl, M Volm: P-glycoprotein and glutathione S-transferase π in childhood acute lymphoblastic leukemia. Br J Cancer 70: 1144-1149, 1994.
27. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
28. Volm M, Mattern J: Expression of topoisomerase II, catalase, metallothionein and thymidylate-synthase in human squamous cell lung carcinomas and their correlation with doxorubicin resistance and with patients' smoking habits. Carcinogenesis 13: 1947-1950, 1992.
29. Efferth T, Mattern J, Volm M: Immunohistochemical detection of P-glycoprotein, glutathione S-transferase and DNA topoisomerase II in human tumors. Oncology 49: 368-375, 1992.
30. Volm M, Mattern J: Detection of multiple resistance mechanisms in untreated human lung cancer. Onkologie 189-194, 1993.